These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23680419)

  • 1. Motor outcomes during hospitalization in Parkinson's disease patients: a prospective study.
    Gerlach OH; Broen MP; Weber WE
    Parkinsonism Relat Disord; 2013 Aug; 19(8):737-41. PubMed ID: 23680419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
    Kroonenberg PM; Oort FJ; Stebbins GT; Leurgans SE; Cubo E; Goetz CG
    BMC Med Res Methodol; 2006 Jun; 6():26. PubMed ID: 16772027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease.
    Verbaan D; van Rooden SM; Benit CP; van Zwet EW; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2011 Sep; 17(8):632-4. PubMed ID: 21696993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.
    Follett KA; Weaver FM; Stern M; Hur K; Harris CL; Luo P; Marks WJ; Rothlind J; Sagher O; Moy C; Pahwa R; Burchiel K; Hogarth P; Lai EC; Duda JE; Holloway K; Samii A; Horn S; Bronstein JM; Stoner G; Starr PA; Simpson R; Baltuch G; De Salles A; Huang GD; Reda DJ;
    N Engl J Med; 2010 Jun; 362(22):2077-91. PubMed ID: 20519680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The usefulness of timed motor tests in assessing Parkinson's disease].
    García-Ruiz PJ; Sánchez-Bernardos V; Cabo-López I
    Rev Neurol; 2009 Jun 16-30; 48(12):617-9. PubMed ID: 19507119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
    Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
    J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurostimulation for Parkinson's disease with early motor complications.
    Schuepbach WM; Rau J; Knudsen K; Volkmann J; Krack P; Timmermann L; Hälbig TD; Hesekamp H; Navarro SM; Meier N; Falk D; Mehdorn M; Paschen S; Maarouf M; Barbe MT; Fink GR; Kupsch A; Gruber D; Schneider GH; Seigneuret E; Kistner A; Chaynes P; Ory-Magne F; Brefel Courbon C; Vesper J; Schnitzler A; Wojtecki L; Houeto JL; Bataille B; Maltête D; Damier P; Raoul S; Sixel-Doering F; Hellwig D; Gharabaghi A; Krüger R; Pinsker MO; Amtage F; Régis JM; Witjas T; Thobois S; Mertens P; Kloss M; Hartmann A; Oertel WH; Post B; Speelman H; Agid Y; Schade-Brittinger C; Deuschl G;
    N Engl J Med; 2013 Feb; 368(7):610-22. PubMed ID: 23406026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small intestinal bacterial overgrowth in Parkinson's disease.
    Tan AH; Mahadeva S; Thalha AM; Gibson PR; Kiew CK; Yeat CM; Ng SW; Ang SP; Chow SK; Tan CT; Yong HS; Marras C; Fox SH; Lim SY
    Parkinsonism Relat Disord; 2014 May; 20(5):535-40. PubMed ID: 24637123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates and the risk factors for emergency room visits and hospitalization in Parkinson's disease.
    Hassan A; Wu SS; Schmidt P; Dai Y; Simuni T; Giladi N; Bloem BR; Malaty IA; Okun MS;
    Parkinsonism Relat Disord; 2013 Nov; 19(11):949-54. PubMed ID: 23835430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P; Batir A; Van Blercom N; Chabardes S; Fraix V; Ardouin C; Koudsie A; Limousin PD; Benazzouz A; LeBas JF; Benabid AL; Pollak P
    N Engl J Med; 2003 Nov; 349(20):1925-34. PubMed ID: 14614167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection is associated with worse severity of Parkinson's disease.
    Tan AH; Mahadeva S; Marras C; Thalha AM; Kiew CK; Yeat CM; Ng SW; Ang SP; Chow SK; Loke MF; Vadivelu JS; Ibrahim N; Yong HS; Tan CT; Fox SH; Lang AE; Lim SY
    Parkinsonism Relat Disord; 2015 Mar; 21(3):221-5. PubMed ID: 25560322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.
    Song J; Fisher BE; Petzinger G; Wu A; Gordon J; Salem GJ
    Neurorehabil Neural Repair; 2009 Sep; 23(7):657-61. PubMed ID: 19336530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of deep-brain stimulation for Parkinson's disease.
    Deuschl G; Schade-Brittinger C; Krack P; Volkmann J; Schäfer H; Bötzel K; Daniels C; Deutschländer A; Dillmann U; Eisner W; Gruber D; Hamel W; Herzog J; Hilker R; Klebe S; Kloss M; Koy J; Krause M; Kupsch A; Lorenz D; Lorenzl S; Mehdorn HM; Moringlane JR; Oertel W; Pinsker MO; Reichmann H; Reuss A; Schneider GH; Schnitzler A; Steude U; Sturm V; Timmermann L; Tronnier V; Trottenberg T; Wojtecki L; Wolf E; Poewe W; Voges J;
    N Engl J Med; 2006 Aug; 355(9):896-908. PubMed ID: 16943402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.